claim: nsp7 and spike glycoprotein of sars-cov-2 are envisaged as potential sources of vitamin d and ivermectin
evidence_1: our study, therefore, opens up avenues for further investigations to consider vitamin d and ivermectin as potential drugs against sars-cov-2.", "we have analyzed available structures of sars-cov-2 proteins to identify probable binding partner(s) of vitamin d and ivermectin through knowledge-based docking studies and figured out possible implication of their binding in sars-cov-2 infection.")